Merger Monday returns ...

It's been a while since several deals have been simultaneously announced at the beginning of the week but there is a possibility of it happening today.

That's because overnight the likes of the Wall Street Journal, the Financial Times and Bloomberg were all reporting US-listed biopharmaceutical company Amgen is close to buying Horizon Therapeutics for around $116.5 a share or around $26 billion. Below are the relevant links:..


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Monday, 12 December 2022, 10:07 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation